TIAA CREF INVESTMENT MANAGEMENT LLC - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 64 filers reported holding GALENA BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q1 2017$19,000
-69.4%
31,8260.0%0.00%
Q4 2016$62,00031,8260.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,702,228$953,0000.06%
Crescent Grove Advisors, LLC 120,000$42,0000.01%
DAFNA Capital Management LLC 46,145$16,0000.01%
Winfield Associates, Inc. 3,000$1,0000.00%
Renaissance Technologies 2,769,786$977,0000.00%
TWO SIGMA SECURITIES, LLC 34,954$12,0000.00%
MEEDER ASSET MANAGEMENT INC 14,646$5,0000.00%
NEXT Financial Group, Inc 25$00.00%
IFP Advisors, Inc 512$00.00%
BNP PARIBAS FINANCIAL MARKETS 3$1,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders